Insider buying
~$1.3K121 sh @ $10.72
Traded Jan 16, 2025 · filed 5 days later
The CEO of Exozymes paid $1.3K out of pocket for Exozymes shares. Shares held went up 6% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jan 17, 2025 · Filed Jan 21, 2025
The CEO of Exozymes paid $19K out of pocket for Exozymes shares. Shares held went up 84% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$19,048
Shares × reported transaction price
<$25K
+83.9%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 2 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider buying
Traded Jan 16, 2025 · filed 5 days later
The CEO of Exozymes paid $1.3K out of pocket for Exozymes shares. Shares held went up 6% with this purchase.
Insider buying
Traded Nov 15, 2024 · filed 4 days later
The CEO of Exozymes paid $22K out of pocket for Exozymes shares. It was the first purchase in over a year.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.